Canada Markets closed
LATEST UPDATE

NO WEEKLY BRIEF NEWSLETTER FOR THE WEEKEND OF OCT. 16-17

We are taking a short break, but we will be back next week. Stay tuned!

ALLK Jan 2022 100.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
10.350.00 (0.00%)
At close: 5:00PM EDT
Full screen
Loading interactive chart...
  • Zacks

    Implied Volatility Surging for Allakos (ALLK) Stock Options

    Investors need to pay close attention to Allakos (ALLK) stock based on the movements in the options market lately.

  • GlobeNewswire

    Allakos Provides Business Update and Reports Second Quarter 2021 Financial Results

    REDWOOD CITY, Calif., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing lirentelimab (AK002) for the treatment of eosinophil and mast cell-related diseases, today provided a business update and reported financial results for the second quarter ended June 30, 2021. Recent Accomplishments Presented new data at Digestive Disease Week (DDW) 2021 suggesting eosinophilic gastritis and/or eosinophilic duodenitis (EG/EoD) is significantly u

  • Motley Fool

    3 Biotech Stocks That Could Double Soon

    Wall Street analysts following these drugmakers think they can produce big gains in a short time frame.